| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/01/2007 | EP1812011A1 Combined use of vitamin d derivatives and anti-proliferative agents for treating bladder cancer |
| 08/01/2007 | EP1812010A2 Use of na+/ k+-atpase inhibitors and antagonists thereof |
| 08/01/2007 | EP1812009A1 Gaba-steroid antagonists and their use for the treatment of cns disorders |
| 08/01/2007 | EP1812008A1 Il-8 receptor antagonists |
| 08/01/2007 | EP1812007A2 Pyridazine compounds and methods |
| 08/01/2007 | EP1812006A2 Methods of using pde v inhibitors for the treatment of congestive heart failure |
| 08/01/2007 | EP1812005A2 Lactam compounds and their use as pharmaceuticals |
| 08/01/2007 | EP1812004A1 Ortho- condensed pyridine and pyrimidine derivatives (e. g. purines) as protein kinases inhibitors |
| 08/01/2007 | EP1812003A1 Ortho- condensed pyridine and pyrimidine derivatives (e. g. purines) as protein kinases inhibitors |
| 08/01/2007 | EP1812002A2 Treatment of mastitis |
| 08/01/2007 | EP1812001A2 Nicotinic-opioid synergy for analgesia |
| 08/01/2007 | EP1812000A1 Aqueous ophthalmic suspension of crystalline rebamipide |
| 08/01/2007 | EP1811999A1 Quinuclidine derivatives and their use as muscarinic m3 receptor antagonists |
| 08/01/2007 | EP1811998A1 Triazoles useful as inhibitors of protein kinases |
| 08/01/2007 | EP1811997A2 Low-molecular inhibitors of cytohesin-family guanine nucleotide exchange factors |
| 08/01/2007 | EP1811996A1 Compositions for treating flushing and lipid-associated disorders comprising niacin receptor partial agonists |
| 08/01/2007 | EP1811995A1 A transmucosal veterinary composition comprising detomidine |
| 08/01/2007 | EP1811994A1 Novel derivatives of porphyrin, particularly chlorins and/or bacteriochlorins, and uses thereof in photodynamic therapy |
| 08/01/2007 | EP1811993A2 Modulators of crth2, cox-2 and faah |
| 08/01/2007 | EP1811991A2 Methods of treating diabetes mellitus |
| 08/01/2007 | EP1811990A1 Anti-demodicosis agent |
| 08/01/2007 | EP1811989A1 Preparation containing oxidized flavonoid derivatives |
| 08/01/2007 | EP1811988A1 Use of acetyl l-carnitine in combination with propionyl l-carnitine and sildenafil for the treatment of erectile dysfunction |
| 08/01/2007 | EP1811987A1 Dry powder comprising levothyroxine sodium administered via inhalator |
| 08/01/2007 | EP1811986A1 Gabapentin prodrug sustained release oral dosage forms |
| 08/01/2007 | EP1811985A1 Nutrient supplement and use of the same |
| 08/01/2007 | EP1811984A1 Compounds which inhibits protein prenylation e.g. geranylgeranyltransferase or farnesyltransferase inhibitors for treating parkinson's disease |
| 08/01/2007 | EP1811983A2 New use for cannabinoid |
| 08/01/2007 | EP1811982A1 Therapeutic treatment of accelerated bone resorption |
| 08/01/2007 | EP1811981A2 Process for the preparation of suspension aerosol formulations, wherein the particles are formed by precipitation inside an aerosol canister |
| 08/01/2007 | EP1811979A2 Microcapsules comprising a methylxanthine and a corticosteroid |
| 08/01/2007 | EP1811973A1 Pharmaceutical compositions comprising (+) - (2s, 3s) - 2 - (chlorophenyl) - 3, 5, 5-trimethhyl-2-morpholinol |
| 08/01/2007 | EP1811972A1 A controlled slow release formulation of thiamine and use thereof in the treatment of pathologies connected to defective process of learning and memorization |
| 08/01/2007 | EP1811967A2 Methods and formulations for making pharmaceutical compositions containing bupropion |
| 08/01/2007 | EP1811965A1 A process for preparing formulations of lipophilic active substances by spray freeze drying |
| 08/01/2007 | EP1811963A2 Methods of treating cancer with lipid-based platinum compound formulations administered intraperitoneally |
| 08/01/2007 | EP1811961A2 Extended surface aggregates in the treatment of skin conditions |
| 08/01/2007 | EP1811957A1 Solid pharmaceutical composition comprising donepezil hydrochloride |
| 08/01/2007 | EP1811956A1 Method of reducing nosocomial infections |
| 08/01/2007 | EP1811867A2 Food composition comprising a protein- and a lipid fraction for rapidly attenuating inflammatory responses |
| 08/01/2007 | EP1811846A2 Methods for making and using synergistic multifunctional compositions |
| 08/01/2007 | EP1811845A2 Substituted biaryl quinolin-4-ylamine analogues |
| 08/01/2007 | EP1811844A1 Methods for diagnosis and treatment of cancer |
| 08/01/2007 | EP1811842A2 3,3'-diindolylmethane immune activating compositions |
| 08/01/2007 | EP1811841A2 Control of parasites in animals by the use of parasiticidal 2-phenyl-3-(1h-pyrrol-2-yl) acrylonitrile derivatives |
| 08/01/2007 | EP1811840A2 Anti-tumor compounds with angeloyl groups |
| 08/01/2007 | EP1811839A2 Methods and compositions related to esculentoside a |
| 08/01/2007 | EP1811838A2 Tweak as a therapeutic target for treating central nervous system diseases associated with cerebral edema and and cell death |
| 08/01/2007 | EP1759703A4 Immunistimulative and interferonogenous agent |
| 08/01/2007 | EP1708716B1 Oral dieting composition comprising conjugated linoleic acid and caffeine |
| 08/01/2007 | EP1706397A4 Novel amorphous form of omeprazole salts |
| 08/01/2007 | EP1601355B1 Diagnostic method for prevision of kidney transplantation rejection |
| 08/01/2007 | EP1589956B1 Transdermal granisetron |
| 08/01/2007 | EP1581528B1 Piperidinyl-thiazole carboxylic acid derivatives as angiogenesis inhibitors |
| 08/01/2007 | EP1581505B1 Pyridazinone derivatives as gsk-3beta inhibitors |
| 08/01/2007 | EP1572071A4 Systems and methods for treating patients with processed lipoaspirate cells |
| 08/01/2007 | EP1565456A4 1,2,4-triazole derivative, method for preparing the same, and pharmaceutical composition containing the same |
| 08/01/2007 | EP1546130B1 Piperidine derivatives for use in the treatment of chemokine mediated disease states |
| 08/01/2007 | EP1537124B1 C-substituted tricyclic isoxazoline derivatives and their use as anti-depressants |
| 08/01/2007 | EP1534704B1 Process for preparing 5-(4-fluorophenyl)-1-¬2-((2r,4r)-4-hydroxy -6-oxo-tetrahydro-pyran-2-yl)ethyl|-2-isopropyl-4-phenyl-1h-pyrrole-3-carboxylic acid phenylamide |
| 08/01/2007 | EP1507760B1 Cyanoguanidine prodrugs |
| 08/01/2007 | EP1496874B1 Transdermal patches having a siliconic adhesive matrix stabilized with methacrylic copolymers |
| 08/01/2007 | EP1487822B1 Pyrrole-2,5-dione derivatives and their use as gsk-3 inhibitors |
| 08/01/2007 | EP1485367B1 Purified citalopram salts |
| 08/01/2007 | EP1484327B1 Nitrogenous heterocyclic compound and medicine thereof |
| 08/01/2007 | EP1480631B1 Methods of treating non-painful bladder disorders using alpha2-delta- subunit calcium channel modulators |
| 08/01/2007 | EP1461326B1 Benzothiazole- and benzoxazole-4,7-dione derivatives and their use as cdc25 phosphatase inhibitors |
| 08/01/2007 | EP1461038B1 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders |
| 08/01/2007 | EP1461037B1 Process for preparation of a beverage treated with a nicotine containing substance |
| 08/01/2007 | EP1424074B1 Nutritional compositions for controlling blood glucose level |
| 08/01/2007 | EP1420804B1 Methods and compositions for control of coccidiosis |
| 08/01/2007 | EP1419158B1 Pteridinone derivatives as modulators of chemokine receptor activity |
| 08/01/2007 | EP1393732B1 Minoxidil-containing liquid composition |
| 08/01/2007 | EP1390754B1 Method and composition for skin grafts |
| 08/01/2007 | EP1377542B1 Hiv protease inhibitors based on amino acid derivatives |
| 08/01/2007 | EP1373194B1 BENZAMIDE INHIBITORS OF FACTOR Xa |
| 08/01/2007 | EP1372681B1 Biologically active chloroform fraction of an extract obtained from a mangrove plant salvadora persica l |
| 08/01/2007 | EP1355904B1 Heterocyclindazole and azaindazole compounds as 5-hydroxytryptamine-6 ligands |
| 08/01/2007 | EP1330468B1 Sulphur analogues of 21-hydroxy-6,19-oxidoprogesterone (21oh-6op) for treating excess of glucocorticoids |
| 08/01/2007 | EP1313715B1 Oxazolyl-aryloxyacetic acid derivatives and their use as ppar agonists |
| 08/01/2007 | EP1303277B1 Pharmaceutical composition based on cocaethylene and use thereof for treating psychoactive substance dependence |
| 08/01/2007 | EP1301168B1 Storage-stable compositions of glycerol monoalkyl ethers |
| 08/01/2007 | EP1294714B1 Thrombin receptor antagonists |
| 08/01/2007 | EP1294698B1 Fused azepine derivatives and their use as antidiuretic agents |
| 08/01/2007 | EP1294401B1 Enhancement of antibody-cytokine fusion protein mediated immune responses by combined treatment with immunocytokine uptake enhancing agents |
| 08/01/2007 | EP1289929B1 Shortened synthesis of 3,3-diarylpropylamine derivatives |
| 08/01/2007 | EP1259235B1 Tyrosine kinase inhibitors |
| 08/01/2007 | EP1248609A4 Method of treating benign forgetfulness |
| 08/01/2007 | EP1217998B1 Use of (+)-tramadol, o-demethyltramadol, o-desmethyl-n-mono-desmethyl-tramadol for treating urinary incontinence |
| 08/01/2007 | EP1187592B1 Alpha v integrin receptor antagonists |
| 08/01/2007 | EP1148882B1 Use of a plasma homocysteine content reducing agent for the reduction of the thromboembolic side effect risk induced by gestagen type hormones |
| 08/01/2007 | EP1141293B1 Vascular endothelial growth factor-x |
| 08/01/2007 | EP1066816B1 Agents promoting laminin production in skin cells |
| 08/01/2007 | EP1062223B1 Composition containing a precursor capable of being hydrolysed by glucocerebrosidase |
| 08/01/2007 | EP1032389B1 CHRONIC, BOLUS ADMINISTRATION OF D-threo METHYLPHENIDATE |
| 08/01/2007 | EP1019060B1 Androgen synthesis inhibitors |
| 08/01/2007 | EP1018879B1 Nitrosated and nitrosylated alpha-adrenergic receptor antagonist compounds, compositions and their uses |
| 08/01/2007 | EP1007537B1 Receptor protein designated 2f1 |
| 08/01/2007 | EP1005470B1 Oxindolylquinazoline derivatives as angiogenesis inhibitors |
| 08/01/2007 | EP0884947B1 Dna vaccination for induction of suppressive t cell response |